Item Type | Name |
Concept
|
Forecasting
|
Academic Article
|
Second-generation tyrosine kinase inhibitors: the future of frontline CML therapy.
|
Academic Article
|
Chronic myelogenous leukemia--past, present, and future.
|
Academic Article
|
Homoharringtonine: history, current research, and future direction.
|
Academic Article
|
Clofarabine: past, present, and future.
|
Academic Article
|
Chronic myelogenous leukemia--update and future directions.
|
Academic Article
|
Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture.
|
Academic Article
|
Future clinical implications for farnesyltransferase inhibitors in hematologic malignancies.
|
Academic Article
|
Current and future management options for myelodysplastic syndromes.
|
Academic Article
|
Advances in therapy for hairy cell leukemia. A review.
|
Academic Article
|
Adult acute lymphocytic leukemia. Future research directions.
|
Academic Article
|
Targeting ABL and SRC kinases in chronic myeloid leukemia: experience with dasatinib.
|
Academic Article
|
Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies.
|
Academic Article
|
First-line therapy for chronic myeloid leukemia: Past, present, and future.
|
Academic Article
|
Acute myeloid leukemia--major progress over four decades and glimpses into the future.
|
Academic Article
|
Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions.
|
Academic Article
|
Future directions in molecular and genetic therapy for Leukemias and solid tumors
|
Academic Article
|
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
|
Academic Article
|
The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy.
|
Academic Article
|
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia.
|
Academic Article
|
Treatment of acute lymphoblastic leukemia in older adults: now and the future.
|
Academic Article
|
Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicin.
|
Academic Article
|
Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives.
|
Academic Article
|
Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring.
|
Academic Article
|
The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types.
|
Academic Article
|
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions.
|
Academic Article
|
Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies.
|
Academic Article
|
Acute myeloid leukemia: current progress and future directions.
|
Academic Article
|
Hypomethylating agents for the treatment of myelodysplastic syndromes and acute myeloid leukemia: Past discoveries and future directions.
|
Academic Article
|
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions.
|